Cyclacel Pharmaceuticals (CYCC) has entered into a securities purchase agreement for the sale of its convertible Series E Preferred Stock in a ...

Cyclacel Pharmaceuticals secured $1.0 million in gross proceeds from a private placement of convertible Series E Preferred Stock, enhancing its financial position. The funding is expected to ...

in a registered public offering by the Company directly to such investor (the “Preferred Stock Offering”), an aggregate of 150,000 shares of new Series F Convertible Preferred Stock (the ...

KKR's gross proceeds from the IPO are $2.25 billion for a total of 45 million convertible preferreds issued at a par value of $50 each. The new preferred stock did not receive a credit rating at ...

KKR expects to grant the underwriters a 30-day option to purchase up to an additional $225 million (4,500,000 shares) of mandatory convertible preferred stock, solely to cover over-allotments ...

Shares of Signet Jewelers (SIG) took off after the jewelry store chain announced it was buying back half of the convertible preferred ... 2025 fiscal year earnings per share (EPS) estimate by ...

The second-quarter results revealed a notable increase in GAAP diluted earnings per share (EPS ... alongside a dividend on ...

The underwriters have a 30-day option to purchase up to an additional $337.50 million (6,750,000 shares) of mandatory convertible preferred stock, solely to cover over-allotments, if any.